Momelotinib (MMB) Long-Term Safety: Pooled Data from Three Phase 3 Randomized-Controlled Trials (RCTs)

被引：1

作者：

Verstovsek, Srdan ^{[1
]}

Mesa, Ruben ^{[2
]}

Gupta, Vikas ^{[3
]}

Lavie, David ^{[4
]}

Dubruille, Viviane ^{[5
]}

Cambier, Nathalie ^{[6
]}

Platzbecker, Uwe ^{[7
]}

Hus, Marek ^{[8
]}

Xicoy, Blanca ^{[9
]}

Oh, Stephen T. ^{[10
]}

Kiladjian, Jean-Jacques ^{[11
]}

Vannucchi, Alessandro M. ^{[12
]}

Gerds, Aaron T. ^{[13
]}

Egyed, Miklos ^{[14
]}

Mayer, Jiri ^{[15
,16
]}

Sacha, Tomasz ^{[17
]}

Kawashima, Jun ^{[18
]}

Morris, Marc ^{[18
]}

Huang, Mei ^{[18
]}

Harrison, Claire ^{[19
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Leukemia Dept, Houston, TX 77030 USA

[2] UT Hlth San Antonio Canc Ctr, San Antonio, TX USA

[3] Univ Hlth Network, Div Med Oncol & Hematol, Toronto, ON, Canada

[4] Hadassah Hebrew Univ, Med Ctr, Jerusalem, Israel

[5] Nantes Univ Hosp, Hematol Dept, Nantes, France

[6] Hosp St Vincent Paul GHICL Lille, Lille, France

[7] Univ Leipzig, Dept Hematol Cell Therapy & Hemostaseol, Med Ctr, Leipzig, Germany

[8] Med Univ Lublin, Lublin, Poland

[9] Univ Autanoma Barcelona, Barcelona, Spain

[10] Washington Univ, Siteman Canc Ctr, Sch Med, St Louis, MO USA

[11] Univ Paris, Hop St Louis, AP HP, Ctr Invest Clin, Paris, France

[12] Univ Florence, Florence, Italy

[13] Cleveland Clin, Dept Hematol & Med Oncol, Taussig Canc Inst, Cleveland, OH USA

[14] Som Cty Mr Kaposi Gen Hosp, Kaposver, Hungary

[15] Masaryk Univ, Brno, Czech Republic

[16] Univ Hosp Brno, Brno, Czech Republic

[17] Jagiellonian Univ Hosp, Krakow, Poland

[18] Sierra Oncol Inc, San Mateo, CA USA

[19] Guys & St ThomasNHS Fdn Trust, London, England

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-162543

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：9670 / 9672

页数：3

共 50 条

[21] SAFETY OF LINACLOTIDE IN PEDIATRIC PATIENTS WITH FUNCTIONAL CONSTIPATION: A POOLED ANALYSIS OF PLACEBO-CONTROLLED RANDOMIZED-CONTROLLED TRIALS
Hyams, Jeffrey S.
Saps, Miguel
Di Lorenzo, Carlo
Rodriguez-Araujo, Gerardo
Xie, Wangang
Huh, Susanna Y.
Weissman, Darren
Khlevner, Julie
Nurko, Samuel
GASTROENTEROLOGY, 2023, 164 (06) : S954 - S954
[22] Safety of linaclotide in pediatric patients with functional constipation: A pooled analysis of placebo-controlled, randomized-controlled trials
Hyams, J. S.
Saps, M.
Di Lorenzo, C.
Rodriguez, G.
Xie, W.
Huh, S. Y.
Weissman, D.
Khlevner, J.
Nurko, S.
NEUROGASTROENTEROLOGY AND MOTILITY, 2023, 35
[23] Suvorexant in Patients with Insomnia: Pooled Analyses of Three-Month Data from Phase-3 Randomized Controlled Clinical Trials
Herring, W. Joseph
Connor, Kathleen M.
Snyder, Ellen
Snavely, Duane B.
Zhang, Ying
Hutzelmann, Jill
Matzura-Wolfe, Deborah
Benca, Ruth M.
Krystal, Andrew D.
Walsh, James K.
Lines, Christopher
Roth, Thomas
Michelson, David
JOURNAL OF CLINICAL SLEEP MEDICINE, 2016, 12 (09): : 1215 - 1225
[24] Fremanezumab Cardiovascular Safety Profile: Pooled Data from Placebo-controlled and Long-term Studies
Ning, X.
Faulhaber, N.
Lang, N.
Yeung, P. P.
Schiemann, J.
Cohen, J. M.
Aycardi, E.
HEADACHE, 2018, 58 : 174 - 175
[25] Momelotinib in Myelofibrosis Patients With Thrombocytopenia: Post Hoc Analysis From Three Randomized Phase 3 Trials
Kiladjian, Jean-Jacques
Vannucchi, Alessandro M.
Gerds, Aaron T.
Gupta, Vikas
Verstovsek, Srdan
Egyed, Miklos
Platzbecker, Uwe
Mayer, Jiri
Grosicki, Sebastian
Illes, Arpad
Wozny, Tomasz
Oh, Stephen T.
McLornan, Donal
Kirgner, Ilya
Yoon, Sung-Soo
Harrison, Claire N.
Klencke, Barbara
Huang, Mei
Kawashima, Jun
Mesa, Ruben
HEMASPHERE, 2023, 7 (11): : E963
[26] LONG-TERM (156-WEEK) SAFETY PROFILE OF APREMILAST, AN ORAL PHOSPHODIESTERASE 4 INHIBITOR, IN PATIENTS WITH PSORIATIC ARTHRITIS: POOLED SAFETY ANALYSIS OF 3 PHASE III, RANDOMIZED, CONTROLLED TRIALS
Mease, P. J.
Gladman, D. D.
Gomez-Reino, J. J.
Hall, S.
Kavanaugh, A.
Lespessailles, E.
Schett, G.
Shah, K.
Teng, L.
Wollenhaupt, J.
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 608 - 608
[27] Long-Term (156-Week) Safety Profile of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Pooled Safety Analysis of 3 Phase III, Randomized, Controlled Trials
Mease, Philip J.
Gladman, Dafna D.
Gomez-Reino, Juan J.
Hall, Stephen
Kavanaugh, Arthur
Lespessailles, Eric
Schett, Georg
Shah, Kamal
Teng, Lichen
Wollenhaupt, Juergen
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[28] Long-term safety of long-acting octreotide in patients with diabetic retinopathy: results of pooled data from 2 randomized, double-blind, placebo-controlled phase 3 studies
Pivonello, Rosario
Muscogiuri, Giovanna
Holder, Geoffrey
Paul, Michaela
Sarp, Severine
Lesogor, Anastasia
Jordaan, Pierre
Eisinger, Johannes
Colao, Annamaria
ENDOCRINE, 2018, 60 (01) : 65 - 72
[29] Long-term safety of long-acting octreotide in patients with diabetic retinopathy: results of pooled data from 2 randomized, double-blind, placebo-controlled phase 3 studies
Rosario Pivonello
Giovanna Muscogiuri
Geoffrey Holder
Michaela Paul
Severine Sarp
Anastasia Lesogor
Pierre Jordaan
Johannes Eisinger
Annamaria Colao
Endocrine, 2018, 60 : 65 - 72
[30] EFFICACY AND SAFETY OF LUSEOGLIFLOZIN IN JAPANESE PATIENTS WITH TYPE 2 DIABETES MELLITUS BASED ON BMI: ANALYSIS OF POOLED DATA FROM LONG-TERM PHASE 3 TRIALS
Sakai, S.
Ubukata, M.
Samukawa, Y.
Sasaki, T.
Haneda, M.
Inagaki, N.
Kaku, K.
Seino, Y.
DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S262 - S263

← 1 2 3 4 5 →